Abstract
Oral bisphosphonates can cause esophageal inflammation, which, in turn, is a risk factor for esophageal cancer. In this case-control study, researchers investigated whether oral bisphosphonate use is associated with esophageal and other gastrointestinal (GI) cancers. The U.K. General Practice Research Database was used …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
